logo
  

Hertz Appoints Former Ford Chief Mark Fields As Interim CEO

Hertz said Tuesday that it has appointed Mark Fields as interim chief executive officer and Paul Stone as president and chief operations officer, effective immediately.

Fields joined Hertz's Board of Directors in June. He also is a senior advisor at TPG Capital and former president and CEO of Ford Motor Company, where he served for 28 years. In addition, he is Lead Independent Director of Tanium and serves on Qualcomm's Board of Directors.

Stone, who formerly was Hertz's CEO, will partner as the company's president and chief operations officer.

Hertz Corp., a subsidiary of Hertz Global Holdings, Inc., operates the Hertz, Dollar and Thrifty vehicle rental brands throughout North America, Europe, the Caribbean, Latin America, Africa, the Middle East, Asia, Australia and New Zealand.

Car-rental company Hertz Global Holdings had emerged from bankruptcy in June 2021.
It had filed for Chapter 11 for its U.S. operations on May 22, 2020. Hertz's principal international operating regions including Europe, Australia and New Zealand were not included in the U.S. Chapter 11 proceedings.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
Follow RTT